Home

Medicamen Biotech Ltd Quarterly Result

Image

Medicamen Biotech Ltd

NSE: MEDICAMEQ

Net Profit - Last Quarter

₹ 0.9 Cr.

Last updated on: Jan 15, 2025

Key Highlights

  • The revenue of Medicamen Biotech Ltd for the Sep '24 is ₹ 45.03 crore as compare to the Jun '24 revenue of ₹ 43.63 crore. This represent the growth of 3.208796%.
  • The ebitda of Medicamen Biotech Ltd for the Sep '24 is ₹ 5.6 crore as compare to the Jun '24 ebitda of ₹ 4.03 crore. This represent the growth of 38.957806%.
  • The net profit of Medicamen Biotech Ltd for the Sep '24 is ₹ 0.9 crore as compare to the Jun '24 net profit of ₹ 0.8 crore. This represent the growth of 12.499995%.

Results Analysis

Market Price of Medicamen Biotech Ltd

1M

1Y

3Y

5Y

Monitoring Medicamen Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
15 Jan 2025475.6
14 Jan 2025483.9
13 Jan 2025472.7
10 Jan 2025479.65
09 Jan 2025495.85
08 Jan 2025507.7
07 Jan 2025517.35
06 Jan 2025494.05
03 Jan 2025525.95
02 Jan 2025523.4

Historical Revenue of Medicamen Biotech Ltd

No data available

* All values are in crore

Historical EBITDA of Medicamen Biotech Ltd

No data available

* All values are in crore

Historical Net Profit of Medicamen Biotech Ltd

No data available

* All values are in crore

Medicamen Biotech Ltd News Hub

Medicamen Biotech consolidated net profit declines 67.70% in the June 2024 quarter

Net profit of Medicamen Biotech declined 67.70% to Rs 1.35 crore in the quarter ended June 2024 as a

Read more

13 Aug 2024

Medicamen Biotech to conduct board meeting

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 13 August 2024. Po

Read more

12 Aug 2024

Medicamen Biotech to conduct AGM

Medicamen Biotech announced that the Annual General Meeting (AGM) of the company will be held on 26

Read more

13 Sep 2024

Medicamen Biotech declare Quarterly Result

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 14 November 2024 P

Read more

08 Nov 2024

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Quarterly Results of Medicamen Biotech Ltd

What key financial metrics are included in Medicamen Biotech Ltd's quarterly results?

Key financial metrics in Medicamen Biotech Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Medicamen Biotech Ltd announce its quarterly results?

Medicamen Biotech Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Medicamen Biotech Ltd's quarterly performance impact its stock price?

Medicamen Biotech Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Medicamen Biotech Ltd's quarterly results on dividends?

The impact of Medicamen Biotech Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Medicamen Biotech Ltd's quarterly results?

Yes, Medicamen Biotech Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions